Literature DB >> 23682439

Ocular diseases among HIV/AIDS patients in Jakarta, Indonesia.

Yeni Dwi Lestari1, Ratna Sitompul, Lukman Edwar, Zubairi Djoerban.   

Abstract

We conducted a survey of ocular diseases among HIV/AIDS outpatients in Jakarta, Indonesia. This cross sectional study was conducted among 311 HIV/ AIDS patients presenting to three referral hospitals in Jakarta, Indonesia from September 2008 to May 2009. All subjects underwent ophthalmological examination, including visual acuity, intraocular pressure, eye movement, Schirmer's test and anterior and posterior segment evaluation. Most subjects (86%) were aged 20-40 years; and 77% were male. Intravenous drug use was the most common risk factor (48.9%) for HIV infection. At the time of enrollment, 85% of subjects were receiving anti-retroviral therapy (ART); the median CD4+ T cell count prior to ART was 56 (0-757) cells/microl. The most common ocular manifestations were dry eye syndrome (54%), followed by toxoplasma retinochoroiditis (8.4%) and cytomegalovirus (CMV) retinitis (5.8%). Risk factors associated with ocular diseases were late HIV clinical stage (OR = 4.35 for clinical stage 4 vs 1; p = 0.001), co-infection (OR = 2.67 for 2 co-infections vs no co-infection; p = 0.009) and low CD4+ T cell count prior to ART (< 50 cells/microl vs > or = 200 cells/microl; p = 0.003). The CD4+ count at the first visit (p = 0.041) and clinical stage (p = 0.049) were associated with dry eyes. This study shows dry eyes were the most prevalent ocular disease among HIV/ AIDS patients in Jakarta. HIV clinical stage 3 or 4, co-infection with tuberculosis and hepatitis C infection and a CD4+ T cell count of <50 cells/microl were risk factors for ocular disease in HIV/AIDS patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23682439

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  3 in total

1.  Challenging treatment of bilateral multiple infection panuveitis in HIV/AIDS patients.

Authors:  Widya Artini; Soedarman Sjamsoe; Made Susiyanti
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

2.  Toluidine Blue 0.05% Vital Staining for the Diagnosis of Ocular Surface Squamous Neoplasia in Kenya.

Authors:  Stephen Gichuhi; Ephantus Macharia; Joy Kabiru; Alain M'bongo Zindamoyen; Hilary Rono; Ernest Ollando; Leonard Wanyonyi; Joseph Wachira; Rhoda Munene; Timothy Onyuma; Walter G Jaoko; Mandeep S Sagoo; Helen A Weiss; Matthew J Burton
Journal:  JAMA Ophthalmol       Date:  2015-11       Impact factor: 7.389

Review 3.  Contribution of HIV Infection, AIDS, and Antiretroviral Therapy to Exocrine Pathogenesis in Salivary and Lacrimal Glands.

Authors:  Imran Nizamuddin; Peter Koulen; Carole P McArthur
Journal:  Int J Mol Sci       Date:  2018-09-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.